30.06.2013 Views

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Lexchin and Caygill point out that <strong>the</strong>re have been eight 31 occasions where<br />

international pharmaceutical companies have bought legal proceedings against<br />

PHARMAC in <strong>the</strong> New Zealand courts. All <strong>of</strong> <strong>the</strong>se cases were successfully<br />

defended by PHARMAC. None <strong>of</strong> <strong>the</strong>se claims could have been regarded as<br />

vexatious (Lexchin & Caygill, 2000). Whilst defending court actions taken<br />

against it is not a particularly desirable use <strong>of</strong> public money by PHARMAC,<br />

equally as a Crown Agency it should not resile from <strong>the</strong> need to publicly defend<br />

its actions. In light <strong>of</strong> this, it would not seem appropriate that PHARMAC should<br />

be protected from this normal level <strong>of</strong> legal jeopardy. If <strong>the</strong> government were to<br />

provide PHARMAC with an extraordinary level <strong>of</strong> legal protection this would<br />

create <strong>the</strong> impression that <strong>the</strong>y are entitled to act in ways that lie outside that<br />

which would be considered normal commercial dealings by <strong>the</strong> Courts.<br />

Past legal actions cannot be a predictor <strong>of</strong> what would have happened if <strong>the</strong> full<br />

exemption from Section II <strong>of</strong> <strong>the</strong> Commerce Act had been removed. This is<br />

because <strong>the</strong> previous actions were taken under <strong>the</strong> protection <strong>of</strong> <strong>the</strong> Commerce<br />

Act. PHARMAC may not have fared so well in <strong>the</strong> nine legal challenges if <strong>the</strong><br />

full force <strong>of</strong> Section II <strong>of</strong> <strong>the</strong> Act had been directed at it.<br />

PHARMAC argued that <strong>the</strong> public benefit <strong>of</strong> saving public funds from litigation<br />

costs outweighs any detriment to <strong>the</strong> pharmaceutical companies and <strong>the</strong><br />

detriment to side stepping <strong>the</strong> controls <strong>of</strong> <strong>the</strong> Commerce Commission.<br />

This Royal Australasian College <strong>of</strong> Surgeons (RACS) also complained that by<br />

<strong>the</strong> Bill granting immunity from Part II <strong>of</strong> <strong>the</strong> Commerce Act, <strong>the</strong> government<br />

owned public health services were taking an unfair advantage over private<br />

health providers.<br />

The RACS submitted that <strong>the</strong>y considered this (immunity) has <strong>the</strong> potential to<br />

disadvantage private providers <strong>of</strong> publicly provided services. This would result<br />

in decreased availability <strong>of</strong> privately provided health services and cause a<br />

higher cost <strong>of</strong> publicly provided care 32 . The College would regret such an<br />

outcome and suggested that private providers <strong>of</strong> publicly funded services, such<br />

as <strong>the</strong>mselves, should also be exempt from <strong>the</strong> provisions <strong>of</strong> <strong>the</strong> Commerce Act<br />

31 Prior to <strong>the</strong> year 2000.<br />

32 See ‘Rent seeking’ on p40<br />

118

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!